Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biodexa Pharmaceuticals plc - American Depositary Shares (NQ:BDRX)

0.8800 -0.0100 (-1.12%)
Streaming Delayed Price Updated: 3:58 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biodexa Pharmaceuticals plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >
Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status
Via ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Crude Oil Rises Sharply; Manhattan Associates Shares Slide
 
Via Benzinga
Biodexa Stock Surges On FDA's Fast-Track Tag For Treatment Of Cancer-Causing Condition: Retail Confidence Peaks
The drug, a proprietary encapsulated form of rapamycin, is being developed for familial adenomatous polyposis (FAP), a condition that, if left untreated, universally leads to colorectal cancer. 
Via Stocktwits
Nasdaq Surges 1%; ON Semiconductor Shares Plunge Following Earnings Miss
 
Via Benzinga
Biodexa's MX-110 Continues to Show Promise in Recurrent Glioblastoma (rGBM), the Deadliest Brain Cancer
Via ACCESSWIRE
How Is The Market Feeling About Biodexa Pharmaceuticals?
 
Via Benzinga
Dow Gains 100 Points; McDonald's Shares Rise After Q4 Results
 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic
Via ACCESSWIRE
BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Why Is Brain Cancer-Focused Biodexa Pharmaceuticals Stock Trading Lower On Thursday?
Biodexa Pharmaceuticals reports updates from the MAGIC-1 study on MTX110 for recurrent glioblastoma. MTX110 has also demonstrated potential in treating diffuse midline glioma, a rare brain cancer, with... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Biodexa Pharmaceuticals Stock Is Soaring After The Close: What's Driving Shares Higher?
Biodexa Pharmaceuticals shares are soaring in Tuesday's after-hours session after the company announced it was granted an extension to demonstrate compliance with Nasdaq listing requirements. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday 
Via InvestorPlace
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Gold Rises Sharply; Methode Electronics Shares Spike Higher
 
Via Benzinga
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
 
Via Benzinga
JOBY Stock Pops After Completing 523-Mile eVTOL Flight
Joby Aviation stock is flying higher on Thursday after the eVTOL company reported a new milestone for a hydrogen-electric aircraft. 
Via InvestorPlace
Cancer-Focused Nano-Cap Biodexa Pharmaceuticals Stock Is Surging On Thursday - Here's Why
Biodexa Pharmaceuticals shares surge following phase 2 trial results for eRapa, a potential treatment for Familial Adenomatous Polyposis. The study showed a 17% median reduction in polyp burden and a... 
Via Benzinga
KZIA Stock Alert: Kazia Continues Its Surge on Thursday With 51% Gains
Kazia Therapeutics stock is still rallying on Thursday with heavy trading of KZIA alongside its latest positive clinical trial data. 
Via InvestorPlace
Why Is Biodexa Pharmaceuticals (BDRX) Up 56% Today?
Biodexa Pharmaceuticals stock is up on Thursday with heavy trading of BDRX shares alongside positive clinical trial news. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.